CFTR and cystic fibrosis: Concerning this, Kelly-Aubert et al. [142] reported that the treatment with a membrane permeable analogue of GSH, i.e., GSH monoethylester (GSH-EE), reverted the reduced mtCx-I activity of CF cells, as well as CFTR knockout mice, to healthy values.